RICHARD BUNT: Open Payments
NPI 1376619072 · PALM BAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,134 in 68 payments from 10 companies in 2025. Trend: 2023 $1,019 · 2024 $1,342 · 2025 $3,134
Travel & lodging: $1,710Food & beverage: $1,424
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $2,155 |
| ABBVIE INC. | 36 | $527 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Lundbeck LLC | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
Products named: VRAYLAR, REXULTI, COBENFY, FANAPT, TRINTELLIX, Auvelity, AUSTEDO XR, Quviviq.
Industry payments across FL — which companies pay providers there.
